Sugi Predict

Sugi Predict / Compounds / SCHEMBL483840

SCHEMBL483840

SCHEMBL483840

Cc1ccc(S(=O)(=O)OCCOCCOCCO)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ CA1 P00915 3/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ STAT3 P40763 2/20 0.43
▸ RECQL P46063 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GAA P10253 2/20 0.39
▸ CYP2D6 P10635 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PSMD10 O75832 1/20 0.38
▸ CA2 P00918 2/20 0.38
▸ MMP2 P08253 2/20 0.38
▸ MMP9 P14780 2/20 0.38
▸ MMP8 P22894 2/20 0.38
▸ MMP13 P45452 2/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30244568 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL16898428 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL15416739 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL1742594 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL916053 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL23417950 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL7519771 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL11516145 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL16899885 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3
SCHEMBL564403 1.00 ALDH1A1 (0.46) ALDH1A1CA1CA12CA9STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119931671-A Silicon-calcium-potassium-magnesium type soil conditioner and preparation method thereof 鄂尔多斯市蒙泰铝业有限责任公司 2025-05-06 — — CN claimed
CN-117717506-B Modified cellulose-based arborescent aloe freeze-dried powder and preparation method thereof 山东爱维德生物科技有限公司 2024-06-04 — — CN claimed
CN-117659319-B Phenolic resin for high-wettability abrasive grinding tool and preparation method thereof 山东宇世巨化工有限公司 2024-04-30 — — CN claimed
CN-117717506-A Modified cellulose-based arborescent aloe freeze-dried powder and preparation method thereof 山东爱维德生物科技有限公司 2024-03-19 — — CN claimed
CN-117659319-A Phenolic resin for high-wettability abrasive grinding tool and preparation method thereof 山东宇世巨化工有限公司 2024-03-08 — — CN claimed
CN-113201132-B Rhodamine B derivative fluorescent probe molecule based on monodisperse four-arm polyethylene glycol and preparation method thereof 长沙创新药物工业技术研究院有限公司 2023-12-01 — — CN claimed
CN-117070138-A Quick-drying alkyd resin paint and preparation method thereof 山东齐鲁漆业有限公司 2023-11-17 — — CN claimed
CN-115991858-B Preparation method of high-temperature-resistant phenolic resin gel material 山东宇世巨化工有限公司 2023-06-02 — — CN claimed
CN-115991858-A Preparation method of high-temperature-resistant phenolic resin gel material 山东宇世巨化工有限公司 2023-04-21 — — CN claimed
US-20230078913-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS ESSA PHARMA INC. (CA) 2023-03-16 — — US claimed
CN-111909163-B Quinolamine compound with IDO1 inhibition function and preparation method thereof 南开大学 2022-02-01 — — CN claimed
WO-2020198711-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS ESSA PHARMA, INC. (CA) 2020-10-01 — — WO claimed
CN-111440076-A Tert-butylamino triglycol type hindered amine and preparation method thereof 中国石油天然气集团有限公司 2020-07-24 — — CN claimed
EP-3658548-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas Operations, Inc. (US) 2020-06-03 — — EP claimed
WO-2019023553-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas, Inc. (US) 2019-01-31 — — WO claimed
CN-105566283-B Chiral crown ether containing ent-Bayesian skeleton and preparation method and application thereof 浙江工业大学 2017-12-05 — — CN claimed
US-20170327469-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR ARVINAS OPERATIONS, INC. 2017-11-16 — — US claimed
CN-105566283-A chiral crown ether containing ent-Bayesian skeleton and preparation method and application thereof UNIV ZHEJIANG TECHNOLOGY 2016-05-11 — — CN claimed
CN-105541633-A open-chain chiral crown ether containing ent-Bayesian skeleton and preparation and application thereof UNIV ZHEJIANG TECHNOLOGY 2016-05-04 — — CN claimed
CN-101791577-B Chiral catalyst, and synthesis and application methods thereof YINGJIANG (TIANJIN) FRAGRANCE AND FLAVOR CO., LTD. (CN) 2011-11-30 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230078913-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS PROTEOLYSIS TARGETING CHIMERA LIGANDS AR, PSMA1, SHBG ALDH1A1 3367/4885CA1 3020/4885CA12 2897/4885
US-20170327469-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AR, MDM2, ESRRA ALDH1A1 514/4885CA1 2519/4885CA12 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.